CEREMONY MARKS HALFWAY POINT FOR CLINCIAL RESEARCH COMPANY CONSTRUCTION
Newark's University Heights Science and Technology Park Welcomes New Neighbor
November 19, 2014
Newark, NJ - Biotrial, a leading clinical research organization based in France that provides drug discovery and developmental services worldwide, held a "Half Way There" ceremony today at the Public Health Research Institute Center in Newark to celebrate a milestone in the construction of its North American headquarters in University Heights Science and Technology Park (UHSTP).
The ceremony marked seven months into the construction with another seven months to go to reach completion on the 70,000 square foot, five-story facility that will occupy approximately 1.2 acres within the city's Central Ward.
"We looked at many locations around the world before selecting Newark and University Heights Science and Technology Park for our North American headquarters," said Jean-Marc Gandon, president and chief executive offer of Biotrial. "The Park's proximity to superior research and medical facilities and to a major transportation center addressed the many key requirements and standards we have for conducting our research."
The new facility will be the center of operations for Biotrial's North American Headquarters and will house a wide variety of laboratory, pharmacy, and clinical facilities, as well as corporate office space.
Joel Bloom, president of NJIT and chairman of UHSTP Board of Trustees, said, "Today marks a significant milestone for Science Park. This ceremony represents the continued momentum for establishing the City of Newark as a world-class science and technology center. More importantly, it means permanent jobs and greatly enhanced purchasing power impacting the surrounding communities."
Biotrial's arrival in Newark marks another significant achievement in the continuing evolution of the science and technology mixed-use Park in the city's Central Ward. This addition further advances the goal to drive economic development for the continued revitalization of the area.
UHSTP leadership has enthusiastically endorsed Biotrial's establishing a major research center within the Park, citing potential opportunities for new significant scientific and economic benefits for Newark and throughout New Jersey. Leaders also expressed praise for Lt. Governor Kim Guadagno for her assistance in attracting Biotrial to the Park.
"With Biotrial as our new neighbor, we look forward to the potential collaborations of our students with their researchers to advance learning, discovery and innovation in the pharmaceutical and biotech industries," said Dr. Brian Strom, Chancellor, Rutgers Biomedical and Health Sciences (RBHS).
Dr. Gale E. Gibson, president of Essex County College, said, "This is a unique opportunity for our region's college students. Biotrial is a real world example of how scientific research translates into real life. We look forward to the experiential education opportunities that may be provided through internships and other partnerships."
Biotrial manages more than 80 drug trials and studies annually many within its own facilities in France and the United Kingdom. It is anticipated that the Biotrial project will create more than 100 permanent healthcare jobs to support the Newark-based operation.
Architecture firm Francis Cauffman completed the master design plan for the facility. The $25 million project is scheduled to be completed in mid-2015.
About University Heights Science and Technology Park
UHSP is a collaborative venture supported by the adjacent education institutions - the University of Medicine and Dentistry of New Jersey (UMDNJ), Rutgers-Newark, New Jersey Institute of Technology (NJIT) and Essex County College - City, State and Federal government, private industry and community groups. Thus far, a total of 351,000 square feet of office, research and technology space in five buildings; a daycare center; and 21 units of owner-occupied housing have been developed within Science Park, and more than 90 incubating companies are located there. The UHSP initiative also developed nearby Science Park High School in partnership with the Newark Public Schools district.
Founded in 1989, Biotrial is a leading CRO specialized in Early Development with a large range of services from Non-Clinical Pharmacology, Phase I studies, Phase II-IV Trial Management, Bioanalysis, Oncology, Data Management, Biostatistics, ECG & Imaging Core Lab (QT/QTc Trials, Psychometric Testing, Imaging, EEG/PSG Assessment), Regulatory Affairs to Medical Writing. Its primary areas of drug therapy research include: allergy, cardiovascular, CNS, dermatology, endocrinology/metabolism, gastroenterology, hematology, immunology, infectious diseases, oncology, respiratory, rheumatology, and women's health.